Alixtra subcutaneous injection 2.5mg, manufactured by Sand Pharma, contains Fondaparinux sodium, a selective factor Xa inhibitor used for the prevention of deep vein thrombosis and pulmonary embolism. This injectable medicine has a YJ code of 3339400G2025 and a standard of 2.5 mg in 0.5 mL per tube.
Alixtra subcutaneous injection 2.5mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →